SEC Info
HomeSearchMy InterestsHelpSign InPlease Sign In

American Renal Associates Holdings, Inc. 10-Kfor12/31/16

On: Wednesday, 3/8/17, at 5:31pm ET For: 12/31/16 Accession #: 1498068-17-12 File #: 1-37751

Previous ‘10-K’: None · Next:10-K’ on 3/6/18 for 12/31/17 · Latest:10-K’ on 3/16/20 for 12/31/19 · 4 References:

Magnifying glass tilted right emoji
inShowandHints

  As Of               Filer                 Filing    ForOnAs Docs:Size

 3/08/17  American Renal Assocs Holdin… Inc 10-K       12/31/16   97:12M

Annual Report Form 10-K Sect. 13 / 15(d) SEA34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.15M 
 2: EX-21.1     Subsidiaries List                                   HTML    106K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     26K 
 4: EX-31.1     Certification -- 302 - SOA'02                      HTML     34K 
 5: EX-31.2     Certification -- 302 - SOA'02                      HTML     33K 
 6: EX-32.1     Certification -- 906 - SOA'02                      HTML     30K 
 7: EX-32.2     Certification -- 906 - SOA'02                      HTML     29K 
14: R1          Document and Entity Information                     HTML     53K 
15: R2          Consolidated Balance Sheets                         HTML    119K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
17: R4          Consolidated Statements of Operations               HTML     94K 
18: R5          Consolidated Statements of Comprehensive Income     HTML     41K 
19: R6          Consolidated Statements of Changes in Equity        HTML    144K 
20: R7          Consolidated Statements of Changes in Equity        HTML     29K 
                (Parenthetical)                                                  
21: R8          Consolidated Statements of Cash Flows               HTML    156K 
22: R9          Presentation                                        HTML     30K 
23: R10         Summary of Significant Accounting Policies          HTML     85K 
24: R11         Initial Public Offering                             HTML     43K 
25: R12         Acquisitions                                        HTML     53K 
26: R13         Fair Value of Financial Instruments                 HTML    114K 
27: R14         Property and Equipment                              HTML     44K 
28: R15         Intangible Assets and Goodwill                      HTML     73K 
29: R16         Accrued Expenses and Other Current Liabilities      HTML     51K 
30: R17         Variable Interest Entities                          HTML     35K 
31: R18         Noncontrolling Interests Subject to Put Provisions  HTML     32K 
32: R19         Changes in Ownership Interest in Consolidated       HTML     50K 
                Subsidiaries                                                     
33: R20         Debt                                                HTML     81K 
34: R21         Leases                                              HTML     65K 
35: R22         Income Taxes                                        HTML    118K 
36: R23         Earnings (Loss) Per Share                           HTML     91K 
37: R24         Equity                                              HTML     38K 
38: R25         Stock-Based Compensation                            HTML    142K 
39: R26         Related Party Transactions                          HTML     40K 
40: R27         Commitments and Contingencies                       HTML     34K 
41: R28         Certain Legal Matters                               HTML     38K 
42: R29         Employee Benefit Plan                               HTML     29K 
43: R30         Concentrations                                      HTML     31K 
44: R31         Selected Quarterly Financial Data (Unaudited)       HTML    106K 
45: R32         Summary of Significant Accounting Policies          HTML    114K 
                (Policies)                                                       
46: R33         Summary of Significant Accounting Policies          HTML     30K 
                (Tables)                                                         
47: R34         Acquisitions (Tables)                               HTML     42K 
48: R35         Fair Value of Financial Instruments (Tables)        HTML    106K 
49: R36         Property and Equipment (Tables)                     HTML     41K 
50: R37         Intangible Assets and Goodwill (Tables)             HTML     72K 
51: R38         Accrued Expenses and Other Current Liabilities      HTML     52K 
                (Tables)                                                         
52: R39         Changes in Ownership Interest in Consolidated       HTML     51K 
                Subsidiaries (Tables)                                            
53: R40         Debt (Tables)                                       HTML     74K 
54: R41         Leases (Tables)                                     HTML     60K 
55: R42         Income Taxes (Tables)                               HTML    118K 
56: R43         Earnings (Loss) Per Share (Tables)                  HTML     88K 
57: R44         Stock-Based Compensation (Tables)                   HTML    126K 
58: R45         Selected Quarterly Financial Data (Unaudited) (     HTML    105K 
                Tables)                                                          
59: R46         Presentation (Details)                              HTML     37K 
60: R47         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     36K 
                Accounts Receivable (Details)                                    
61: R48         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     34K 
                Property and Equipment (Details)                                 
62: R49         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     30K 
                Amortizable Intangible Assets (Details)                          
63: R50         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     27K 
                Identified Non Amortizable Intangible Assets and                 
                Goodwill (Details)                                               
64: R51         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     39K 
                Impairment of Long Lived Assets (Details)                        
65: R52         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     39K 
                Recent Accounting Pronouncements (Details)                       
66: R53         Initial Public Offering (Details)                   HTML    126K 
67: R54         Acquisitions (Details)                              HTML     49K 
68: R55         Fair Value of Financial Instruments (Details)       HTML     79K 
69: R56         Property and Equipment (Details)                    HTML     48K 
70: R57         Intangible Assets and Goodwill (Details)            HTML     49K 
71: R58         Intangible Assets and Goodwill - Estimated annual   HTML     42K 
                amortization expense (Details)                                   
72: R59         INTANGIBLE ASSETS AND GOODWILL - Changes in the     HTML     33K 
                value of goodwilll (Details)                                     
73: R60         Accrued Expenses and Other Current Liabilities      HTML     46K 
                (Details)                                                        
74: R61         Variable Interest Entities (Details)                HTML     29K 
75: R62         Noncontrolling Interests Subject to Put Provisions  HTML     38K 
                (Details)                                                        
76: R63         Changes in Ownership Interest in Consolidated       HTML     44K 
                Subsidiaries (Details)                                           
77: R64         Debt (Details)                                      HTML     67K 
78: R65         Debt - Credit And Interest Rate Swap Agreements     HTML    106K 
                (Detail)                                                         
79: R66         Leases (Details)                                    HTML    102K 
80: R67         Income Taxes (Details)                              HTML     47K 
81: R68         Income Taxes - Significant components of deferred   HTML     66K 
                tax assets and liabilities (Details)                             
82: R69         INCOME TAXES - Reconciliation of the federal        HTML     49K 
                statutory rate (Details)                                         
83: R70         Earnings (Loss) Per Share (Details)                 HTML     68K 
84: R71         Equity (Details)                                    HTML     48K 
85: R72         STOCK-BASED COMPENSATION - Share Based              HTML     51K 
                Compensation Plans & Shares reserved (Details)                   
86: R73         STOCK BASED COMPENSATION - Equity Grants,           HTML     33K 
                Assumptions and Activity (Details)                               
87: R74         STOCK-BASED COMPENSATION - Weighted - average       HTML    101K 
                assumptions and stock option activity (Details)                  
88: R75         STOCK BASED COMPENSATION - Stock options and        HTML     38K 
                compensation costs (Details)                                     
89: R76         Related Party Transactions (Details)                HTML     80K 
90: R77         Commitments and Contingencies (Details)             HTML     29K 
91: R78         Certain Legal Matters (Details)                     HTML     32K 
92: R79         Employee Benefit Plan (Details)                     HTML     27K 
93: R80         Concentrations (Details)                            HTML     26K 
94: R81         Selected Quarterly Financial Data (Unaudited)       HTML     49K 
                (Details)                                                        
96: XML         IDEA XML File -- Filing Summary                      XML    171K 
95: EXCEL       IDEA Workbook of Financial Reports                  XLSX    105K 
 8: EX-101.INS  XBRL Instance -- ara-20161231                        XML   2.23M 
10: EX-101.CAL  XBRL Calculations -- ara-20161231_cal                XML    277K 
11: EX-101.DEF  XBRL Definitions -- ara-20161231_def                 XML    609K 
12: EX-101.LAB  XBRL Labels -- ara-20161231_lab                      XML   1.70M 
13: EX-101.PRE  XBRL Presentations -- ara-20161231_pre               XML   1.15M 
 9: EX-101.SCH  XBRL Schema -- ara-20161231                          XSD    198K 
97: ZIP         XBRL Zipped Folder -- 0001498068-17-000012-xbrl      Zip    202K 





Filing Submission 0001498068-17-000012 – SGML Text

Original SGML Text submitted by: American Renal Associates Holdings, Inc.

To view the SGML, please refresh
Counterclockwise arrows button emoji
this page.


Top

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Jun. 17, 4:47:07.1am ET